{"title": "PDF", "author": "PDF", "url": "https://www.samfyc.es/wp-content/uploads/2018/08/AlertaDiciembre2014.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Diciembre 2014 Selecci\u00f3n realizada por Antonio Manteca Gonz\u00e1lez ANNALS OF INTERNAL MEDICINE LeFevre ML; U.S. Preventive Services Task Force. Low -dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. [M,III] 25200125 R/C USO DE ASPIRINA EN DOSIS BAJA PARA LA PREVENCI\u00d3N DE LA MORBILIDAD Y MORTALIDAD EN LA PREECLAMPSIA: DECLARACI\u00d3N DE RECOMENDACI\u00d3N DEL USPSTF Isakov A, Jamison A, Miles W, Ribner patients with serious communicable -830 [AO,I] 25244492 MANEJO DE LOS PACIENTES CON ENFERMEDADES TRANSMISIBLES GRAVES: EXPE RIENCIA RECIENTE CON EL VIRUS DE L \u00c9BOLA Zakher B, Cantor AG, Pappas M, Daeges M, Nelson HD. Screeni ng for gonorrhea and Chlamydia: a systematic review for the U.S. Preventive PARA EL USPSTF LeFevre ML; U.S. [M,II] 25244227 R/C INTERVENCIONES DE CONSEJO CONDUCTUAL PARA PREVENIR LAS INFECCIONES DE TRANSMISI\u00d3N SEXUAL: DECLARACI\u00d3N DE RECOMENDACI\u00d3N DEL USPSTF LeFevre ML; U.S. Preventive Services Task Force. Screening for Chlamydia and gonorrhea: U.S. Preventive Services RECOMENDACI\u00d3N DEL USPSTF ARCHIVOS DE BRONCONEUMOLOGIA Lopez -Campos JL, Lopez -Ramirez C, -Mart\u00edn E. enferme dad pulmonar obstructiva cr\u00f3nica CONDENSACI\u00d3N RADIOL\u00d3GICA: TRES PREGUNTAS CONTROVERTIDAS Boixeda R, Bacca S, Elias L, Capdevila JA, Vil\u00e0 X, Mauri M, et al. La neumon\u00eda como comorbilidad en la enfermedad OBSTRUCTIVA CR\u00d3NICA (EPOC) Gonz\u00e1lez N, Troncoso MF, G\u00f3mez T. Terapias ventilatorias domiciliarias en el s\u00edndrome de apnea -hipopnea del sue\u00f1o. 2014;50:528 -534 [R,I] 25059585 VENTILATORIAS DEL SUE\u00d1O ARTHRITIS AND RHEUMATOLOGY Yoo JJ, Cho NH, Lim SH, Kim HA. Relationships between body mass index, fat mass, muscle mass, GRASA, MASA MUSCULAR Y DOLOR OSTEOMUSCULAR EN RESIDENTES EN LA COMUNIDAD ATENCION PRIMARIA Mora RM. Concilia ci\u00f3n y prescripci\u00f3n electr\u00f3nica. Aten Primaria 2014;46:529 -530 [AO,I] 25458923 CONCILIACI\u00d3N Y PRESCRIPCI\u00d3N ELECTR\u00d3NICA L\u00f3pez -Torres J, Basora J, Orozco D, Bell\u00f3n J\u00c1. Mapa bibliom\u00e9trico de la inve stigaci\u00f3n realizada en atenci\u00f3n primaria en Espa\u00f1a durante el periodo 2008 -2012. Aten Primaria 2014;46:541 -548 [T,I] 24811538 R/C MAPA BIBLIOM\u00c9TRICO DE LA INVESTIGACI\u00d3 N REALIZADA EN ATENCI\u00d3N PRIMARIA EN ESPA\u00d1A DURANTE EL PERIODO 2008 -2012 Gancedo -Garc\u00eda A, Guti\u00e9rrez -Antezana AF, Gonz\u00e1lez -Garc\u00eda P, Salinas -Herrero S, Prieto -Merino D, Su\u00e1rez -Gil P. Efectividad de una intervenci\u00f3n educativa breve en pacientes con insomnio en atenci\u00f3n primaria. Aten Primaria 2014;46:549 -557 [EC,I] 24986634 R/C EFECTIVIDAD DE UNA INTERVENCI\u00d3N EDUCATIVA BREVE EN PACIENTES CON INSOMNIO EN ATENCI\u00d3N PRIMARIA Maestre -Miquel C, Mart\u00ednez D, Polonio B, Astasio P, Santos J, Regidor E. Desigualdades en inactividad f\u00edsica seg\u00fan el nivel de estudios en Espa\u00f1a, en 1987 y 2007. Aten Primaria 2014;46:565 -572 [T,I] 24863857 R/C DESIGUALDADES EN INACTIVIDAD F\u00cdSICA SEG\u00daN EL NIVEL DE ESTUDIOS EN ESPA\u00d1A, EN 1987 Y 2007 Catal\u00e1 -L\u00f3pez F, Tob\u00edas A, Roqu\u00e9 M. Conceptos b\u00e1sicos del metaan\u00e1lisis en red. Aten Primaria 2014;46:573 -581 [R,I] R/C CONCEPTOS B\u00c1SICOS DEL METAAN\u00c1LISIS EN RED BRITISH JOURNAL OF PSYCHIATRY Savic C, Belkic K. Why are LABORALES? Livingston G, Kelly L, Lewis -Holmes E, Baio G, Morris S, Patel N, et al. Non -pharmacological interventions f LA DEMENCIA: REVISI\u00d3N SISTEM\u00c1TICA DE ENSAYOS CONTROLADOS ALEATORIZADOS Fountoulakis KN, Kawohl W, Theodorakis PN, Kerkhof AJ, H\u00f6schl C, et al. Relationship of rates to economic SUICIDIO CON VARIABLES ECON\u00d3MICAS EN EUROPA: 2000 -2011 BRITISH MEDICAL JOURNAL Wood LN, MUJERES TK. Lung canc er. BMJ 2014;349:g6560 [R,I] 25376443 C\u00c1NCER DE PULM\u00d3N Hahn JY, Song YB, Choi SH, Choi JH, Lee SH, et al. Angiotensin receptor blocker in patients DE ANGIOTENSINA E N PACIENTES CON INFARTO DE MIOCARDIO CON ELEVACI\u00d3N DEL SEGMENTO ST CON FUNCI\u00d3N SIST\u00d3LICA VENTRICULAR PRESERVADA: ESTUDIO DE DIAGN\u00d3STICO Y TRATAMIENTO DE NEUMON\u00cdA ADQUIRIDA EN LA COMUNIDAD Y ADQUIRIDA EN EL HOSPITAL EN ADULTOS: RESUMEN DE LA GU\u00cdA NICE Hole B, Whittlestone P, Vivian -Griffiths S, Boivin J, Williams A, Venetis CA, Davies A, et al. The association between exaggeration in health related science news ASOCIACI\u00d3N ENTRE EXAGERACI\u00d3N EN LAS NOTICIAS CIENT\u00cdFICAS RELACIONADAS CON LA SALUD Y LOS COMUNICADOS DE PRENSA ACAD\u00c9MICOS Chew M, Brizzell C, Abbasi K, Godlee ties. BMJ 2014;349:g7197 [AO,I] 25432164 REVISTAS M\u00c9DICAS Y LAZOS CON LA INDUSTRIA Neville R, Austin S. The King Canute GP appointment system. BMJ 2014;349:g7228 [QE,I] 25500115 SISTEMA DE CITAS DE MEDICINA GENERAL DEL REY CANUTO Brunet M. Target diagnosis rates [R,I] 25467381 LOS OBJETIVOS DE TASAS DIAGN\u00d3STICAS EN ATENCI\u00d3N PRIMARIA SON ENGA\u00d1OSOS Y POCO \u00c9TICOS Meerman R, Brown AJ. When ALGUIEN LA GRASA? Arroll B, Alrutz S, Moyes S. An exploration of basis for patient complaints about the oldness 262 [S,I] 25500116 R/C EXPLORACI\u00d3N DE LA BASE DE LAS QUEJAS DE LOS PACIENTES SOBRE LA ANTIG\u00dcEDAD DE LAS REVISTAS EN LAS SALAS DE ESPERA DE LAS CONSULTAS: ESTUDIO DE CO HORTE Page VJ. Delirium care unit. BMJ 2014;349:g7265 [AO,I] EN [AO,I] 25512331 DESEQUILIBRIO DE PODER ENTRE PACI ENTES Y M\u00c9DICOS Singleton N, Strang J. What POL\u00cdTICA FARMACOL\u00d3GICA BASADA EN LA EVIDENCIA? Wilkinson R, Pickett K. How C\u00d3MO NOS EST\u00c1 DEFRAUDANOD EL CAPITALISMO EN EL SIGLO 21 CANADIAN MED ICAL ASSOCIATION JOURNAL Poonai N, Bhullar G, Lin K, Papini A, Mainprize D, Howard J, et al. Oral administration morphine ibuprofen ORAL MORFINA A IBUPROFENO PARA TRATAR EL DOLOR POSTFRACTURA EN NI\u00d1OS: ENSAYO ALEATORIZADO Frank C, Pap test. CMAJ [AO,I] 2014;186:E689 Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a re port of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014;130:2071 -2104 [M,III] 24682348 GU\u00cdA AHA/ACC/H RS 2014 MANEJO DE PACIENTES CON FIBRILACI\u00d3N AURICULAR: RESUMEN EJECUTIVO: INFORME DEL ACC/GRUPO DE TRABAJO SOBRE GU\u00cdAS DE PR\u00c1CTICA CL\u00cdNICA DE LA January CT, Jr, et al. 2014 AHA/ACC/H RS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014;130:e199 -e267 [M,III] 24682347 GU\u00cdA AHA/ACC/HRS 2014 PARA DE PACIENTES CON FIBRILACI\u00d3N AURICULAR: INFORME DEL ACC/GRUPO DE TRABAJO SOBRE GU\u00cdAS DE PR\u00c1CTICA CL\u00cdNICA DE LA AHA/HRS Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, et al. Body mass index and the risk of all -cause mortality among patients with [S,II] 25378546 R/C IMC Y RIESGO DE MORTALIDAD POR CUALQUIER CAUSA ENTRE PACIENTES CON DIABETES TIPO 2 Carnethon MR. Diabetes in the absence of obesity: OBESIDAD: ESTADO DE RIESGO DIABETES CARE Cefalu WT, Petersen MP, Ratner RE. The alarming and rising costs of diabetes and prediabetes: a call for a ction! Diabetes Care 2014;37:3137 -3138 [AO,I] 25414386 LOS COSTES EN ASCENSO Y ALARMANTES DE LA DIABETES Y LA PREDIABETES: \u00a1LLAMAMIENTO A LA ACCI\u00d3N! Spijkerman AM, van der A DL, Nilsson PM, Arda naz E, Gavrila D, Agudo A, et al; InterAct Consortium. Smoking and long-term risk of type 2 diabetes: the EPIC -InterAct -3171 [S,II] 2533674 9 R/C TABAQUISMO Y RIESGO DE DIABETES TIPO 2 A LARGO PLAZO : ESTUDIO EPIC -INTERACT EN POBLACIONES EUROPEAS Dall TM, Yang W, Halder P, Pang B, Massoudi M, Wintfeld N, et al. levels in 2014;37:3172 -3179 [T,II] 25414388 R/C LA CARGA ECON\u00d3MICA DE LOS NIVELES ELEVADOS DE AZ\u00daCAR EN SANGRE EN 2012: DIABETES DIAGNOSTICADA Y SIN DIAGNOSTICAR, DIABETES MELLITUS GESTACIONAL Y PREDIABETES Yki-J\u00e4rvinen H, Bergenstal R, Ziemen glargine 300 units/mL versus glargine 100 in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6 -month A LA GLARGINA 100 UU/ML EN PERSONAS CON DIABETES TIPO 2 QUE USAN AGENTES ORALES E INSULINA BASAL: CONTROL DE GLUCOSA E JHIPOGLUCEMIA EN UN ENSAYO CONTROLADO ALEATORIZADO (EDITION 2) Retnakaran R, Kramer CK, Choi H, Swaminathan -cell function in early type 2 Care 2014 ;37:3270 -3278 [EC,I] 25249651 R/C LIRAGLUTIDA Y PRESERVACI\u00d3N DE LA FUNCI\u00d3N DE LA C\u00c9LULA BETA PANCRE\u00c1TICA EN LA DIABETES TIPO 2 TEMPRANA: ENSAYO 2 diabetes: [EC,I] 2524 9652 R/C TRATAMIENTO DE P\u00c9RDIDA DE PESO EN LA DIABETES TIPO 2: EFECTOS DE LA FENTERMINA Y EL TOPIRAMATO DE GESTACIONAL: REVISI\u00d3N SISTEM\u00c1TICA Y METAAN\u00c1LISIS DE ENSAYOS CL\u00cdNICOS ALEATORIZADOS SOBRE LOS RESULTADOS MATERNOS Y DE LOS RECI\u00c9N NACIDOS DRUGS Luke JJ, Ott PA, Shapiro PARA EL C\u00c1 NCER Carris NW, Taylor JR, Gums Combining a GLP -1 receptor agonist and basal R/C RECEPTORES GLP -1 E INSULINA BASAL: EVIDENCIA DE LOS ESTUDIOS Y CONSIDERACIONES PR\u00c1CTICAS Scott LJ. Rifaximin: a review of its USO PARA REDUCIR LAS RECURRENCIAS DE LOS EPISODIOS DE ENCEFALOPAT\u00cdA HEP\u00c1TICA MANIFIESTA Scott LJ. Liraglutide: a revi ew of its use in adult mellitus. Drugs 2014;74:2161 -2174 [R,I] 25367717 R/C LIRAGLUTIDA: EN PACIENTES ADULTOS CON DIAB ETES MELLITUS TIPO 2 Frampton JE. Pramipexole extended -release: a review of its use PROLONGADA: REVISI\u00d3N DE SU USO EN PACIENTES CON ENFERMEDAD DE PARKINSON Plosker GL. Dapagliflozin: a review of its use in diabetes. Drugs 2014;74:2191 -2209 [R,I] 25389049 R/C DAPAGLIFLOZINA: REVISI\u00d3N DE SU USO EN PACIENTES CON DIABETES TIPO 2 ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Garc\u00eda -San Miguel L, Cobo J, Mart\u00ednez JA, A rnau JM, Murillas J, Pe\u00f1a C, et al; el Grupo REIPI. La \u00abintervenci\u00f3n del tercer d\u00eda\u00bb: an\u00e1lisis de los factores asociados al seguimiento de recomendaciones sobre la prescripci\u00f3n D\u00cdA\u00bb: AN\u00c1LISIS DE LOS FACTORES ASOCIADOS AL SEGUIMIENTO DE RECOMENDACIONES SOBRE LA PRESCRIPCI\u00d3N DE ANTIBI\u00d3TICOS Hern\u00e1ndez -Navarrete M J, Celorrio -Pascual JM, Lapresta C, JOURNAL Kolandaivelu K, Leiden BB, O'Gara PT, Bhatt -3276 [R,I] 25265973 R/C FALTA CUMPLIMIENTO DE LA MEDICACI\u00d3N CARDIOVASCULAR Banegas JR, Ruilope LM, de la Sierra A, de la Cruz JJ, Gorostidi M, Segura J, et al. High prevalence of masked uncontrolled hypertension in -3312 [T,II] 24497346 R/C ALTA PREVALENCIA OCULTA DE LA HIPERTENSI\u00d3N SIN CONTROL AR EN PERSONAS CON HIPERTENSI\u00d3N TRATADA FAMILY PRACTICE Burton C. Can we 25192903 R/C ESTRATEGIAS DE RETIRADA DE LOS INHIBIDORES DE LA BOMBA DE PROTONES: REVISI\u00d3N SISTEM\u00c1TICA Glass GE, Tzafetta K. Bell's palsy: a BELL: RESUMEN DE LA EVIDENCIA ACTUAL Y ALGORITMO DE DERIVACI\u00d3N Booth HP, Prevost TA, Wright AJ, LA S INTERVENCIONES CONDUCTUALES PARA LA P\u00c9RDIDA DE PESO EN UN DISPOSITIVO DE ATENCI\u00d3N PRIMARIA: REVISI\u00d3N SISTEM\u00c1TICA Y METAAN\u00c1LISIS Doos L, Roberts EO, REVISI\u00d3N SISTEM\u00c1TICA Clarey J, Lasserson D, Levi C, Parson s M, Dewey H, Barber PA, et al. Absolute cardiovascular risk and GP decision making in ABSOLUTO Y TOMA DE DECISIONES DEL M\u00c9DICO GENERAL EN EL AIT Y EL ICTUS MENOR Schieber AC, Delpierre C, Lepage B, Afrite A, Pascal J, C, et al; R/C DIFERENCIAS DE SEXO A LA INTERACCI\u00d3N M\u00c9DICO -PACIENTE DURANTE LAS CONSULTAS DE MEDICINA GENERAL? RESULTADOS DEL ESTUDIO INTERMEDE Darlow B, Dean S, Perry M, Mathieson F, Baxter GD, Dowell A. Acute low EN MEDICINA GENERAL: INCERTIDUMBRE Y CERTEZAS CONFLICTIVAS GACETA SANITARIA L\u00f3pez -Cepero J, Lana A, Rodr\u00edguez -Franco L, Pa\u00edno SG, Rodr\u00edguez -D\u00edaz FJ. Percepci\u00f3n y etiquetado de la experiencia violenta en las relaciones de noviazgo juvenil. Gac Sanit 2015;29:21 -26 [T,I] 25176129 R/C PERCEPCI\u00d3N Y ETIQUETADO DE LA EXPERIENCIA VIOLENTA EN LAS RELACIONES DE NOVIAZGO JUVENIL Aguilar -Palacio I, Carrera -Lasfuentes P, Rabanaque MJ. Salud percibida y nivel educativo en Espa\u00f1a: tendencias por comunidades aut\u00f3nomas y sexo (2001 -2012) Gac Sanit 2015;29:37 -43 [T,I] 25127554 R/C SALUD PERCIBIDA Y NIVEL EDUCATIVO EN ESPA\u00d1A: TENDENCIAS POR COMUNIDADES AUT\u00d3NOMAS Y SEXO (2001 -2012) L\u00f3pez-Torres J, Rabanales J, Fern\u00e1ndez R, L\u00f3pez FJ, Panad\u00e9s L, Romero V. Resultados de un programa de telemedicina para pacientes con diabetes tipo 2 en atenci\u00f3n primaria. Gac Sanit 2015;29:55 -58 [QE,I] 25440441 R/C RESULTADOS DE UN PROGRAMA DE TELEMEDICINA PARA PACIENTES CON DIABETES TIPO 2 EN ATENCI\u00d3N PRIMARIA JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION Saini SD, van Hees F, CRIBAJE INTELIGENTE RETOS DE LA PERSONALIZACI\u00d3N Gibbons RJ. Optimal medical therapy vs CT JAMA 2014;312:2219 - [AO,I] 25402605 TRATAMIENTO M\u00c9DICO \u00d3PTIMO FRENTE A CRIBAJE ANGIOGR\u00c1FICO POR TC E N PACIENTES CON DIABETES Muhlestein JB, Lapp\u00e9 DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of with diabetes: [EC,II] 25402757 DEL CRIBAJE DE ENFERMEDAD ARTERIAL CORONARIA MEDIANTE ANGIOGRAF\u00cdA POR TC SOBRE LA MORTALIDAD Y LO S ACONTECIMIENTOS CARDIOVASCULARES EN PACIENTES DE ALTO RIESGO CON DIABETES: ENSAYO CL\u00cdNICO ALEATORIZADO FACTOR -64 Nabhan C, Rosen Diekema DJ, Perencevich EN. Ebola virus disease and the need new personal protective equipment. JAMA 2014;312:2495 -2496 [AO,I] 25350321 ENFERMEDAD POR VIRUS DEL \u00c9BOLA Y NECESIDAD DE NUEVOS EQUIPOS DE PROTECCI\u00d3N INDIVIDUAL Gaziano JM, Greenland P. When should aspirin be used for of cardiovascular events? JAMA 2014;312:2503 - 2504 [AO,I] 254026 71 \u00bfCU\u00c1NDO SE DEBER\u00cdA USAR LA ASPIRINA EN LA PREVENCI\u00d3N DE ACONTECIMIENTOS CARDIOVASCULARES? Eckel RH. Role of glycemic index in the -healthy JAMA 2014;312:2508 -2509 [AO,I] 25514301 PAPEL DEL \u00cdNDICE EN EL CONTEXTO DE UNA DIETA CARDIOSALUDABLE GLOBAL Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, S, et al. Low -dose aspirin for primary prevention of cardiovascular events in Japanese patie nts 60 years or older with atherosclerotic DOSIS BAJA EN LA PREVENCI \u00d3N PRIMARIA DE ACONTECIMIENTOS CARDIOVASCULARES EN PACIENTES JAPONESES DE 60 A\u00d1OS O M\u00c1S CON FACTORES DE RIESGO ATEROSCLER\u00d3TICOS: ENSAYO CL\u00cdNICO ALEATORIZADO Sacks FM, Carey VJ, Anderson CA, Miller ER 3rd, Copeland T, Charleston J, et al. Effects of high v s low glycemic index of dietary carbohydrate on DE \u00cdNDICES GLUC\u00c9MICOS ALTOS FRENTE A BAJOS DE CARBOHIDRATOS EN LA DIETA SOBRE LOS FACTORES DE RIESGO DE ENFERMEDAD CARDIOVASCULAR Y LA SENSIBILIDAD A LA INSULINA: ENSAYO CL\u00cdNICO ALEATORIZADO OMNICARB Langa KM, Levine DA. and DIAGN\u00d3STICO Y MANEJO DEL DETERIORO JAMA INTERNAL MEDICINE McDonagh impairment world: you'll live longer, but you might not like it. JAMA Intern Med 2014;174:1889 [AO,I] 25347692 DETERIORO COGNITIVO RELACIONADO CON LAS ESTATINAS EN EL MUNDO REAL: VIVIR\u00c1S M\u00c1S, PERO PUEDE QUE NO TE GUSTE Garin N, Genn\u00e9 D, Carballo S, Chuard C, Eich G, Hugli COMBINADO BETA -LACT\u00c1MICOS Y MACR\u00d3LIDOS EN LA NEUMON\u00cdA ADQUIRIDA EN LA COMUNIDAD MODERADAMENTE GRAVE: ENSAYO DE NO INFERIORIDAD ALEATORIZADO Rostron [T,II] 25317719 R/C C\u00c1LCULO DE LA MORBILIDAD ATRIBUIBLE A CONSUMO DE CIGARRILLOS E N EE UU Moore TJ, Glenmullen J, Mattison DR. Reports HIPERSEXUALIDAD Y COMPRAS COMPULSIVAS ASOCIADOS A F\u00c1RMACOS AGONISTAS DE RECEPTORES DE DOPAMINA Cook NR, Ridker PM. Further insight into roles of statins, revascularizations, and underascertainment [S,II] 25285455 REFLEXI\u00d3N POST ERIOR RIESGO CARDIOVASCULAR: PAPELES DE LAS ESTATINAS, REVASCULARIZACIONES E INFRAESTIMACI\u00d3N EN EL ESTUDIO WOMEN'S HEALTH IDENTIFICACI\u00d3N DE ESTENOSIS CAROT\u00cdDEA EN PACIENTES ASINTOM\u00c1TICOS Woolf SH, Harris RP, Campos -Outcalt D. Low -dose computed tomography screening for lung PAR A EL C\u00c1NCER DE PULM\u00d3N: \u00bfCU\u00c1N FUERTE ES LA EVIDENCIA? JAMA PSYCHIATRY Bryant RA, Kenny L, Joscelyne A, Rawson N, Maccallum F, Cahill EL DUELO PROLONGADO: ENSAYO ALEATORIZADO Pinto SM, Geoffroy MC, Power C. Depressive symptoms and activity during Y DURANTE 3 D\u00c9CADAS EN LA VIDA ADULTA: ASOCIACIONES BIDIRECCIONALES EN UN ESTUDIO DE COHORTE PROSPECTIVO Nordentoft O, al. of depression, depressiv e TRATAMIENTO ANTIINFLAMATORIO SOBRE LA DEPRESI\u00d3N, LOS S\u00cdNTOMAS DEPRESIVOS Y EFECTOS ADVERSOS: REVISI\u00d3N SISTEM\u00c1TICA Y METAAN\u00c1LISIS DE ENSAYOS CL\u00cdNICOS ALEATORIZADOS MEDICINA Posso M, Brugulat P, Puig T, Mompart -Penin a A, Medina -Bustos A, Alca\u00f1iz M, et al. Prevalencia y condicionantes de la obesidad en la poblaci\u00f3n infantojuvenil de Catalu\u00f1a, 24661534 R/C CONDICIONANTES DE LA OBESIDAD EN LA POBLACI\u00d3N INFANTOJUVENIL DE CATALU\u00d1A, 2006 -2012 Ripoll\u00e9s -de Ram\u00f3n J, Mu\u00f1oz -Corcuera M, Bravo -Llatas C, Bascones -Mart\u00ednez A. Aplicaci\u00f3n de un gel de \u00e1cido tranex\u00e1mico en pacientes tr atados DE DE \u00c1CIDO TRANEX\u00c1MICO EN PACIENTES TRATADOS CON ANTICOAGULAN TES ORALES Serra -Majem L. Obesidad infantil: \u00bfhemos tocado E, Vald\u00e9s Nieto -Rodr\u00edguez JA, Ruiz -Rib\u00f3 MD, Cort\u00e9s AB. Utilidad de la cistatina C como marcador pron\u00f3stico en la enfermedad DE MARCADOR PRON\u00d3STICO EN LA ENFERMEDAD TROMBOEMB\u00d3LICA VENOSA Ruiz-Salas A, Cort\u00e9s -Rodr \u00edguez M, Alegre -Garc\u00eda J, de Teresa E, Jim\u00e9nez -Navarro MF. Relaci\u00f3n entre cistatina C y calcificaci\u00f3n coronaria en pacientes con riesgo cardiovascular intermedio. Med Clin (Barc) 2014;143:535 - 538 [T,I] 24725853 R/C RELACI\u00d3N ENTRE CISTATINA C Y CALCIFICACI\u00d3N CORONARIA EN PACIENTES CON RIESGO CARDIOVASCULAR INTERMEDIO Mi\u00f1ambres I, de Leiva A, P\u00e9rez A. Hipovitaminosis D y s\u00edndrome metab\u00f3lico. Med Clin (Bar c) 2014;143:542 -547 [R,I] 24529881 R/C MC, Mart\u00ednez -Herv\u00e1s I, Rodr\u00edguez -Lozano I, Arias -D\u00edaz J. Percepci\u00f3n del fraude cient\u00edfico en las revistas biom\u00e9dicas espa\u00f1olas. Med Clin (Barc) 2014;143:554 -559 [R,I] 25073824 PERCEPCI\u00d3N DEL FRAUDE CIENT\u00cdFICO EN LAS REVISTAS BIOM\u00c9DICAS ESPA\u00d1OLAS SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE Liira H, Engberg E, Lepp\u00e4vuori J, From S, Kautiainen H, Liira J, et al. Exercise intervention and health checks for middle - aged elevated cardiovascular risk: a randomized controlled 2014;32:156 -162 [EC,I] 25434409 R/C INTERVENCI\u00d3N CON EJERCICIO Y PRUEBAS DE SALUD EN HOMBRES DE MEDIANA EDAD CON RIESGO CARDIOVASCULAR ELEVADO: EN SAYO CONTROLADO ALEATORIZADO Aakhus E, Oxman -179 [C,T,I] 25431340 R/C DETERMINA NTES DE CUMPLIMIENTO DE LAS RECOMENDACIONES PARA PACIENTES ANCIANOS DEPRIMIDOS EN ATENCI\u00d3N PRIMARIA: ESTUDIO PLURIMETODOL\u00d3GICO Lenander C, -186 [EC,I] 25347723 R/C EFECTOS DE UNA REVISI\u00d3N ESTRUCTURADA DE LA MEDICACI\u00d3N POR PARTE DEL FARMAC\u00c9UTICO EN ATENCI\u00d3N PRIMARIA SOBRE LOS PROBLEMAS EN RELACI\u00d3N CON LOS F\u00c1RMACOS Y SOBRE LAS TASAS DE INGRESO EN HOS PITAL: ENSAYO CONTROLADO ALEATORIZADO Jansen K, Schaufel MA, Ruths S. Drug treatment at the end of life: an epidemiologic study in nursing homes. -192 [S,I] R/C FARMACOL\u00d3GICO K, Strandberg EL, Gr\u00f6ndal H, Brorsson A, Thulesius H, M. of with sore throats relation to guidelines: an 2014;32:193 -199 [C,I] 25363143 R/C MANEJO DE LOS PACIENTES CON DOLORES DE GARGANTA EN RELACI\u00d3N CON LAS GU\u00cdAS: ESTUDI O MEDIANTE ENTREVISTAS EN SUECIA Huibers 25350313 R/C PAUTAS DE PRESCRIPCI\u00d3N DE ANTIBI\u00d3TICOS EN ATENCI\u00d3N CONTINUADA EN ATENCI\u00d3N PRIMARIA: ESTUDIO DESCRIPTIVO POBLACIONAL Johansson C, H\u00e4gg L, Johansson L, Jansson JH. Characterization of fibrillation not 2014;32:226 -231 [T,I] CARACTERIZACI\u00d3N DE LOS PACIENTES CO N FIBRILACI\u00d3N AURICULAR NO TRATADOS CON ANTICOAGULANTES ORALES Diaz E, Gimeno -Feliu LA, Calder\u00f3n -Larra\u00f1aga A, Prados -Torres A. Frequent attenders in general practice and immigrant status in Norway: a nationwide cross -sectional study. Scand -240 [T,I] 25421090 R/C HIPERFRECUENTADORES EN MEDICINA GENERAL Y CONDICI\u00d3N DE INMIGRANTE EN NORUEGA: ESTUDIO TRANSVERSAL NACIONAL Nilsson S, Andersson A, Janzon M, Karlsson JE, Levin L\u00c5. Cost consequences a Swedish primary health -247 [S,I] 25434410 R/C CON SECUENCIAS DE COSTE DE LA PRUEBA R\u00c1PIDA DE TROPONINA T EN UN DISPOSITIVO DE ATENCI\u00d3N PRMARIA DE SALUD SUECO THE LANCET Hill MD, Coutts SB. Alteplase in acute Glycaemic control, cardiovascular disease, diabetes. Lancet 2014;384:1906 -1907 [AO,I] 25088436 CONTROL GLUC\u00c9MICO, ENFERMEDAD CARDIOVASCULAR Y MORTALIDAD EN LA DIABETES TIPO 2 Williams R, Aspinall R, Bellis M, Camps -Walsh G, Cramp M, Dha wan A, et al. Addressing disease in the UK: a of 2014;384:1953 [M,II] 25513438 ABORDAJE DE LA ENFERMEDAD HEP\u00c1TICA EN R.U.: PLAN DE ACCI\u00d3N PARA ALCANZAR LA EXCELENCIA EN LA ATENCI\u00d3N SANITARIA Y REDUCIR LA MORTALIDAD PREMATURA A PARTIR DE CUESTIONES DE H\u00c1BITOS COMO EL CONSUMO EXCESIVO DE ALCOHOL, OBESIDAD HEPATITITS V\u00cdRICA Roberts I, Perner A. Ebola 25483156 ENFERMEDAD POR EL VIRUS DEL \u00c9BOLA: ATENCI\u00d3N CL\u00cdNICA E INVESTIGACI\u00d3N ENFOCADA AL PACIENTE Schr\u00f6der FH, Hugosson J, Roobol MJ, Prostate Cancer (ERSPC) PR\u00d3STATA: RESULTAD OS DEL ESTUDIO ERSPC TRAS 13 A\u00d1OS Drug labelling and pregnancy. Lancet 2014;384:2084 [AO,I] 25497185 ETIQUETADO DE MEDICAMENTOS Y EMBARAZO THE NEW ENGLAND JOURNAL OF MEDICINE Colombo A, Chieffo A. Dual antiplatelet therapy AM, Fast Wood D, Dye C, Kieny MP, et al. Ebola vaccine MH. How to Engl J Med LA EQUIDAD S ANITARIA Gonsalves G, Staley P. Panic, paranoia, and P\u00c1NICO, PARANOIA Y SALUD P\u00daBLICA --LECCIO NES EPID\u00c9MICAS DEL SIDA PARA EL \u00c9BOLA Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, et al. Cytisine versus nicotine for --a tobacco -2430 [AO,I] 25517710 CITISINA -- TRATAMIENTO THORAX P\u00e9pin EL PARA REDUCIR LA PRESI\u00d3N ARTERIAL EN LA APNEA OBSTRUCTIVA DEL SUE\u00d1O M\u00cdNIMAMENTE SINTOM\u00c1TICA? Halpin DM, INHALADOS EN LA EPOC Bratton JR, Barb\u00e9 F, Kohler M. Effect on pressure LA PRESI\u00d3N ARTERIAL EN PACIENTES CON APNEA OBSTRUCTIVA DEL SUE\u00d1O M\u00cdNIMAMENTE SINTOM\u00c1TICA: METAAN\u00c1LISIS USANDO DATOS INDIVIDUALES DE PACIENTES DE CUATRO ENSAYOS CONTROLADOS ALEATO RIZADOS are at for STIs. (B recommendation). S25200125 The USPSTF recommends ow-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia. (B recommendation). S25243785 The aged 24 years or younger and in older women who are at increased risk for infection. (B recommendation) The USPSTF recommends screening for gonorrhea in sexually active females age d 24 years or younger and in older women who are at increased risk for infection. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men. (I statement). S25244000 Chlamydia screening in young infl in asymptomatic persons. ARCHIVOS BRONCONEUMOLOGIA S25443591 Nuestros datos confirman diferencias cl\u00ednicas y anal\u00edticas entre una AEPOC y una NEPOC en los pacientes que precisan ingreso hospitalario, aunque sin diferencias en la evoluci\u00f3n posterior. S25059585 El s\u00edndrome de apnea -hipopnea del sue\u00f1o es una enfermedad muy prevalente, con tasas altas de infradiagn\u00f3stico en el momento actual, que conlleva un elevado impacto sanitario, econ\u00f3mico y social, y consume gran parte de los recursos destinados a las terapias respiratorias domiciliarias. Con motivo del A\u00f1o SEPAR 2014 del paciente cr\u00f3nico y las terapias respiratorias domiciliarias, p atrocinado por la Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica, en este art\u00edculo se revisa la literatura m\u00e1s reciente publicada sobre las indicaciones del tratamiento de la apnea del sue\u00f1o y sus controversias, las \u00faltimas evidencias de las indicaciones de los dis tintos dispositivos de presi\u00f3n positiva, as\u00ed como los modos de ajuste, desde el uso de f\u00f3rmulas emp\u00edricas o estimaciones matem\u00e1ticas , a los modernos equipos de auto -CPAP, pasando por la titulaci\u00f3n manual como \u00abgold standard\u00bb. Adem\u00e1s, se hace hincapi\u00e9 en la nec esidad de seguimiento que los pacientes precisan para asegurar la adherencia y cumplimiento de la terapia. Por \u00faltimo, se comentan someramente otros tratamientos, que no son el objetivo del art\u00edculo. ARTHRITIS AND RHEUMATOLOGY S25185757 Increased fat ma ss and with musculoskeletal pain among Widespread pain was associated mass ratio after adjustment for confounders. Understanding the relationsh ip between fat ma ss and may provide into preventative PRIMARIA CATALA -LOPEZ Las revisiones sistem\u00e1ticas y los metaan\u00e1lisis se han consolidado como una herramienta fundamental para la pr\u00e1 ctica cl\u00ednica basada en la evidencia. Inicialmente, el metaan\u00e1lisis fue propuesto como una t\u00e9cnica que podr\u00eda mejorar la precisi\u00f3n y la potencia e stad\u00edstica de la investigaci\u00f3n procedente de estudios individuales con peque\u00f1o tama\u00f1o muestral. Sin embargo, u no de sus principales inconvenientes es que suelen comparar no m\u00e1s de 2 intervenciones alternativas a la vez. Los \u00abmetaan\u00e1lisis en red\u00bb utilizan t\u00e9 cnicas novedosas de an\u00e1lisis que permiten incorporar la informaci\u00f3n procedente de comparaciones directas e in directas a partir de una red de estudios que examina los efectos de diversos tratamientos de una manera m\u00e1s completa. Pese a sus potenciales limitaciones, su aplicaci\u00f3n en epidemiolog\u00eda cl\u00ednica podr\u00eda ser potencialmente \u00fatil en situaciones en las que exist en varios tratamientos que se han comparado frente a un comparador com\u00fan. Adem\u00e1s, estas t\u00e9cnicas pueden ser relevantes ante una pregunta cl\u00ednica o de investigaci\u00f3n cuando existen m\u00faltiples tratamient os que deben ser considerados, o cuando se dispone tanto de informaci\u00f3n directa como indirecta en el cuerpo de la evidencia. S24863857 La prevalencia de inactividad f\u00edsica descendi\u00f3 entre 1987 y 2007, y los mayores descensos fueron en sujetos con estudios universitarios. La brecha de las diferencias en prevalenc ias y OR de inactividad f\u00edsica en tiempo libre, ha aumentado con el tiempo. Parece necesario contribuir, desde estrategias de Educaci\u00f3n para la Salud y promoci\u00f3n de la equidad, a la reducci\u00f3n de las desigualdades en conductas de riesgo. S24986634 Implemen tar una intervenci\u00f3n educativa breve en AP mejora la calidad del sue\u00f1o y potencia una menor prescripci\u00f3n de benzodiacepinas. S24811538 En las publicaciones de atenci\u00f3n primaria existe gran diversidad tanto en \u00e1reas de investigaci\u00f3n como en las revistas don de se publican. La mayor\u00eda proceden de centros de salud, tratan aspectos cl\u00ednicos y se publican en revistas espa\u00f1olas. Se observan diferencias en el volumen de producci\u00f3n cient\u00edfica entre comunidades aut\u00f3nomas. BRITISH JOURNAL OF PSYCHIATRY S25452601 Background Agitation in dementia is common, persistent and symptomatic se vere agitation in care homes immediately (SES range 0.3 -1.8) and for up to 6 afterwards (SES range 0.2 -2.2). Activities efficacy. Conclusions There are evidence -based strategies for care homes. Future interventions should focus on consistent and long -term implementation through staff training. Further research is needed for people living in their own homes. S25452599 Work -related mental health disorders are a major problem. occupational/stress medicine. integrate health services for these patients, aimed at preservation of work fitness and mental health. S25359926 Overall, this study confirms a general relations hip between the economic environment and suicide rates; however, it does not support there being a clear causal relationship between the current economic crisis and an increase in the suicide rate. BRITISH MEDICAL JOURNAL S25225003 Urinary incontinence affects women of all ages. History, physical and helpful the of urgency incontinence magazines to the supply of old ones. Gossipy magazines were more likely to disappe ar than non -gossipy ones. On the grounds of cost we practices to supply old copies of non ACE inhibitors in such patients. S25498121 Exaggeration in press releases. Improving the accuracy of academic key opportunity for reducing misleading health related news. CANADIAN MEDICAL ASSOCIATION JOURNAL S25349008 We found no significan t difference in orally administered and effect ive for in with uncomplicated fractures. CIRCULATION S25378546 -The current study indicated of BMI with all -cause mortality risk among African American and white patients with type 2 diabetes. A significantly increase d risk of all -cause mortality was the its contribution to development of metabolic and cardiovascular diseases, a growing number of studies have investigated this ty given the importance of obesity in the etiology of diabetes and the development of complications. In this week's issue of Circulation, Zhao and colleagues2 a U association between weight status and mortality amo ng some,3,4 but findings. DIABETES CARE S25414390 A GI diet was associated birth weight sustained over 48 weeks in T2DM but lost upon cessation of therapy. S25193531 Gla-300 was as effective as Gla -100 and associated with a lower risk of hypoglycemia during the night and at any time of the day. S25336749 Former and current smoking was associated with a higher risk of incident type 2 diabetes compared with never smoking in men and women, independent of educational level, physical activity, alcohol consumption, and diet. Smoking may be regarded as a modif iable risk factor for type 2 diabetes, and smoking cessation should be encouraged for diabetes prevention. S25414388 These statistics the importance of finding ways to reduce the burden of prediabetes and diabetes through preventio n and treatment. Dapagliflozin reduces drugs. This article updates an earlier review of dapagliflozin and focuses on longer -term efficacy and tolerability data (e.g. from extensions of earlier clinical trials), as well as data from studies in special effects are maintained over longer -term follow -up periods of -4 years and dapagliflozin is generally well tolerated. Dapagliflozin has a women) are the common events. Dapagliflozin is not recommended in patients with moderate severe renal impairment. In view of its unique mechanism of act ion and now well -established efficacy t olerability profile, dapagliflozin is a useful treatment option in the management of type 2 diabetes, although its effects on diabetic complications remain goals. Considering this and the increasing incidence of 2 diabetes worldwide, the need for therapy is pressing. Basal treat type injectable, which initial from providers, evidence for their combined use is substantial. This review summarizes the theoretical benefit, supporting evidence, and implementat ion of a combined basal insulin -GLP-1 receptor agonist insulin redu ces HbA1c meal insulin, a GLP similar or hypoglycemia. initiation expected adverse events that come with using a GLP -1 receptor agonist. Basal insulin can be added to a GLP-1 receptor agonist with a slow titration to target goal fasting plasma glucose. In patients starting a GLP -1 receptor agonist, the dose of basal insulin should be decreased by 20 % in patients with an HbA1c =8 The prospec tive studies supports the combined use of a GLP -1 receptor agonist with basal insulin in a broad range of approved for the treatment of adult patients with type 2 diabetes mellitus. Once -daily liraglutide, as or tolerated treatment in adult patients in several well -designed phase III trials and in to Liraglutide regimen, continues to be a useful option for the management of type 2 diabetes. This article reviews the therapeutic use of liraglutide in adult patients with type 2 diabetes and summarizes motor symptoms at stages of Parkinson's disease (PD). It is administered orally and a three -times daily immediate -release (IR) formula tion and of patients can be switched overnight from pramipexole IR to ER with out the need for dosage adjustment. In terms of improving activities of than placebo as monotherapy in patients with early PD, similar to pramipexole and more placebo advanced PD. In -term (80 -week) extensions of these trials, open -label treatment with pramipexole ER was associated with sustained symptomatic benefit. Moreover, the majority of was generally t new or the IR formulation. Head -to-head trials are needed in order to fully define the role of pramipexole ER relative to other once -daily lactulose, is approved in several countries, including the UK, and USA, for use in adults with liver disease to reduce antibacterial that acts locally in the gut to including ammonia -producing sp ecies, with hyperammonaemia considered to play a central role in the pathogenesis of HE. In a 6 -month, multinational trial in patients with liver disease, and well tolerated treatment for reducing study end, rifaximin therapy significantly prolonged the time to the first breakthrough episode compared with placebo (\u00b1 lactulose), irrespective life compared with placebo. Furthermore, the efficacy of rifaximin with or without lactulose in reducing t he recurrence of overt HE episodes w as maintained after up to 2.5 years of treatment, with no new safety signals arising during this period. This article reviews the pharmacology and therapeutic efficacy of rifaximin 550 mg reducing the recurrence of signaling pathway and are of interest the anti -cancer therapeutics. The MAPK/ERK pathway is dysregula ted in more than 30 % of cancers, predominately by mutations in RAS BRAF proteins, and MEK serves as a potential downstream target both of the se. The biology of MEK inhibition is complex, as the molecule is differentially regulated by upstream RAS or RAF. This has impacted on the past development of MEK inhibitors as treatments for cancer rational, selected development of MEK in cancer and the in standard practice, as well as those most advanced in clinical development, are discussed . Finally, next steps ENFERMEDADES INFECCIOS AS Y MICROBIOLOGIA CLINICA S24813928 Una elevada proporci\u00f3n de tratamientos antibi\u00f3ticos son susceptibles de modificaci\u00f3n, generalmente hacia la simplificaci\u00f3n. L a adherencia a las recomendaciones fue elevada, aunque variable, dependiendo del centro, del tipo de recomendaci\u00f3n, del periodo del estudio y de que la recomendaci\u00f3n se realizara mediante un comentario verbal adem\u00e1s de escrito. S25023372 Este art\u00edculo pretende realizar una breve revisi\u00f3n de los principales conceptos en los que se basan las medidas de prevenci\u00f3n y control de la infecci\u00f3n. La antisepsia comprende el conjunto de t\u00e9cnicas destinadas a la eliminaci\u00f3n total (esterilizaci\u00f3n) o mayorit aria (desinfecci\u00f3n) de los g\u00e9rmenes que contaminan un medio. Ambos procedimientos deben ir precedidos de u na limpieza del medio donde se vayan a aplicar. La desinfecci\u00f3n se lleva a cabo por medio de biocidas o germicidas, sustancias qu\u00edmicas antimicrobianas cuyos mecanismos de a cci\u00f3n y resistencia son muy similares a los de los antibi\u00f3ticos. Esta similitud est \u00e1 generando inquietud por la posibilidad de cruce de informaci\u00f3n gen\u00e9tica que agrave el problema de las resistencias bacterianas. La mayor\u00eda de los biocidas pueden actuar como antis\u00e9pticos, aplicados sobre piel y tejidos, o desinfectantes, sobre materiales inanimados. El espectro de acci\u00f3n de los germicidas depende de las caracter\u00edsticas propias del producto y de factores externos controlables: temperatura, concentraci\u00f3n, tiempo d e exposici\u00f3n, etc. Las t\u00e9cnicas de esterilizaci\u00f3n son fundamentalmente de car\u00e1 cter f\u00edsico, a trav\u00e9s de autoclaves que exponen el material a vapor o gas esterilizante. Los mayores avances est\u00e1n en las exposiciones a bajas temperaturas con tiempos m\u00e1s cortos de exposici\u00f3n, en pa ralelo con los avances tecnol\u00f3gicos de instrumentaci\u00f3n co n materiales que no soportan temperaturas elevadas y con rotaciones de uso altas, por la presi\u00f3n asistencial. EUROPEAN HEART JOURNAL S24497346 The prevalence of masked in patients with treated and well -controlled clinic BP is high. Clinic BP monitoring alone is thus inadequate to optimize BP control because patients have higher risk groups and/or those with borderline -based interventions, coronary heart disease As patient of -based practice resulting therapeutic increases adverse cardiac including mortality. Yet, non -adherence is complex, remains difficult to define, and provider ability to identify its presence accurately remains limited. -adherence PRACTICE improve diagnostic that of age GPs' initial focus upon tissue injury 29% which is severe and disfiguring in over half of these cases. Acute medical management remains the best way to are time -dependent. As family practitioners see, on average, one case every 2 years, a summary of this condition based on common clinical questions may improve acute management guide referral for tho se who need specialist input. We formulated a series of clinical questions likely to be of use to family practitioners on encoun tering this condition and sought evidence from the literature to answer them. The lifetime risk is 1 in 60, and is more common in pregnan cy and diabetes mellitus. Patients often present with facial pain or paraesthesia, altered taste and intolerance to lou d in facial droop. It is probably caused by of the facial nerve within the meatal segment of the facial canal proba bly as a result of viral inflammation. When given early, supported by As the facial muscles remain viable re -innervation targets for up to 2 referrals require complex reconstructions. Early recognition, steroid referral for (when the diagnosis is secure) are important features of good management these complex cases. Patient -doctor the consultation. body weight, which unlikely be clinically significant. More effective management strategies for key for older populati ons safely reduce discontinue treatment. Tapering seems to be the most effective way o f doing this. GACETA SANITARIA S25176129 Varones y mujeres se enfrentan a violencia de pareja durante el noviazgo de forma diferente, y ser\u00eda necesario disponer de re cursos para atenderlos de manera espec\u00edfica. Incluir preguntas sobre la sensaci\u00f3n de atr apamiento podr\u00eda contribuir a detectar precozmente la violencia de pareja. Formas de violencia sutiles, como la coerci\u00f3n, deber\u00edan tenerse m\u00e1s en cuenta en las campa\u00f1as de sensibilizaci\u00f3n. S25440441 Aunque no se ha observado una mejor\u00eda en el control gluc\u00e9 mico a lo largo del seguimiento, la transmisi\u00f3n electr\u00f3nica de la informaci\u00f3n ha resultado viable y satisfactoria para los pacientes, en quienes se ha comprobado un mayor nivel de salud percibida. S25127554 En Espa\u00f1a existen diferencias en la prevalencia d e mala salud percibida por CC.AA. Aunque no var\u00eda en el periodo analizado, se observan desigualdades en su evoluci\u00f3n seg\u00fan el nivel educativo y el sexo, que podr\u00edan conllevar un aumento de las desigualda des en mujeres seg\u00fan el nivel educativo. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION S25461996 Chemoimmunotherapy is the standard first -line option most common is initiated when the Among asymptomatic patients with type 1 or type 2 diabetes, use of CCTA to screen for CAD did not reduce the composite rate o f all- cause mortality, nonfatal MI, or unstable angina requiring hospitalization at 4 years. These findings do n ot support CCTA screening in this In -week levels, or diet, -dose aspirin did n ot significantly reduce the risk of the composite outcome nonfatal stroke, and care be skilled identifying mental MCI. INTERNAL MEDICINE S25285455 Statin do explain the discrepancy between observed ra tes of ASCVD in estimate that US adults have had approximately 14 million major medical conditi ons that were attributable to smoking. This figure is generally conservative owing to the existence of other diseases and medical events that were not included in these estimates. Cigarette smoking remains a leading cause of preventable disease in the Unit ed States, underscoring the need for continuing and vigorous smoking -prevention efforts. S25317533 In 2013, low -dose smokers wit h a B recommendation (indicating a level of certainty that it offered moderate to substantial net benefit). Under Affordable Care Act, the USPSTF recommendation requires commercial insurers Centers for & demonstrated the efficacy of low -dose CT, implementation of national screening may be premature. The magnitude of benefit from routine screening is uncertain; estimates are based on data from a single study and simulation models commissioned by the USPSTF. routine screening would result in net benefit or net harm. The NLST may not be generalizable to a national screening program for the Medicare age group because 73% of NLST screening of trial conditions is less likely to be restricted to high - risk smokers and qualified imaging centers with responsible referral protocols. Until better agonist are associated with thes e specific impulse control present, none of the dopamine agonist drugs approved by the FDA have boxed warnings as part of their prescribing information. Our data, and data from prior studies, show the need for cerebrovascular ischemia. The premises of such testing are the potential benefit of endarterectomy or stenting e xceeds the potential harm in asymptomatic asymptomatic stenosis may trigger beneficial changes in lifestyle o patie nts at increased cardiovascular that carotid imaging beha risk factors. In this focused review, we address topics that should help health care pro no role for ion and, in turn, depressive symptoms in early adulthood may be a barrier to activity. S25322082 Our analysis a high risk of bias and high heterogeneity made the mean estimate uncertain. This study supports a proof - of-concept concerning the use of anti -inflammatory treatment in depression. Identification of subgroups that could ch anges in appraisals about the loss, which associated CLINICA S24268907 La aplicaci\u00f3n del \u00e1cido tranex\u00e1mico en gel (Kin Ex ogel) en pacientes en tratamiento con anticoagulantes orales favorece el grado de cicatrizaci\u00f3n y la coagulaci\u00f3n en las primeras 48 -72 h. S24529881 El s\u00edndrome metab\u00f3lico y la hipovitaminosis D constituyen 2 trastornos con elevada prevalencia que comparten diversos factores de riesgo y existen amplias evidencias epidemiol\u00f3gicas que los relacionan. Aunque los mecanismos implicados en esta asociaci\u00f3n n o est\u00e1n bien establecidos, se ha relacionado la hipovitaminosis D con la resistencia a la insulina, la dismin uci\u00f3n en la secreci\u00f3n de insulina o la activaci\u00f3n del sistema renina -angiotensina, mecanismos implicados en la fisiopatolog\u00eda del s\u00edndrome metab\u00f3lico. Sin embargo, la aparente ineficacia de la suplementaci\u00f3n con vitamina D sobre los componentes del s\u00edndrom e metab\u00f3lico, as\u00ed como la escasa informaci\u00f3n acerca del efecto de la mejor\u00eda del control de los componentes del s\u00edndrome metab\u00f3lico sobre las concentra ciones de vitamina, no permiten establecer los mecanismos ni la direcci\u00f3n de la relaci\u00f3n causal entre est as 2 afecciones. En general, por la alta prevalencia y la asociaci\u00f3n epidemiol\u00f3gica de ambos procesos, podr\u00eda considerarse la hipovitaminosis D un componente m\u00e1s del s\u00edndrome metab\u00f3lico. S24480290 El doble tratamiento antiagregante con \u00e1cido acetilsalic\u00edli co y clopidogrel reduce considerablemente las complicaciones tromb\u00f3ticas de las fases aguda y cr\u00f3nica en la cardiopat\u00eda isqu\u00e9mica. Pese al buen cumplimiento terap\u00e9utico, un porcentaje no despreciable d e pacientes contin\u00faa presentando episodios adversos. Po r ello, nuevos compuestos farmacol\u00f3gicamente m\u00e1s favorables est\u00e1n ya disponibles cl\u00ednicamente (como es el caso de prasugrel y ticagrelor) o en fases avanzadas de su desarrollo. La presente revis i\u00f3n tiene como objetivo principal la descripci\u00f3n de los nuevos f\u00e1rmacos antiagregantes, en especial prasugrel y ticagrelor. S24661534 La obesidad y el sobrepeso en la poblaci\u00f3n infantojuvenil catalana se han mantenido estables durante 2006 -2012, siendo de las m\u00e1s altas de Europa. Para afrontar este importante problem a de salud p\u00fablica, es necesario un enfoque integral e interdisciplinario que considere tanto los determinantes sociales como los estilos de vida del entorno infantil. S24725853 Los valores de CTC podr\u00edan asociarse con el CAC y con el riesgo de enfermedad coronaria. Es necesaria la aparici\u00f3n de nuevos estudios para conocer la importancia de estos marcadores en la pr\u00e1ctica cl\u00ednica habitual. S24216017 La concentraci\u00f3n de cisC en el momento del diagn\u00f3stico de los pacientes con ETEV tiene valor pron\u00f3stico, simi lar al de creatinina s\u00e9rica e inferior al del NT -proBNP. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE S25464863 Among patients with AF without OAC treatment a reason could be identified to withhold OAC in 75%. The underuse of OAC is esti mated to be 25%. S25350313 Antibiotics were terms, The use of POCT -TnT in primary care may be cost saving but at the expense of missed cases. S25431340 A total of 352 determinants were identified, of which 99 were prioritized. The most frequently identified factor s had to do with dissemination of guidelines, general practitioners' time constraints, the low with for medication. Approximately three -quarters of the determinants were fr om three of the seven domains in the generic checklist: individual healthcare professional factors, patient resources. The survey did not provide useful information due to a low response rate and a lack of responses to open -ende questions. Implications. The with The home patients on the last day of life. Improvements i n end -of- life care in nursing primary care team may contribute to reductions in numbers of drugs and maintenanc e of self rated with polypharmacy. S25434409 increased in all study groups of middle -aged men in this health -promotion trial. The interventions had no effect on metabolic syndrome or other cardiovascular outcomes in the participan ts. The trial increased awareness and collaboration in physical activity immigrants account for a all and policy -makers should of throat management in a strategically sampled group of Swedish GPs showed that while two -thirds were non-adherent and had a atti tude one were guideline had primary care had not. Guideline implementation thus seemed to be promoted by knowledge shared in team discussions. THE LANCET S25108889 In this update prostate absolute effect at 13 years compared with and 11 years. Despite our findings, further quantification of harm s and their reduction are considered a prerequisite for the introduction of populated -based screening. THE NEW ENGLAND JOUR NAL OF MEDICINE S25517706 When combined with brief behavioral support, cytisine was to nicotine -replacement therapy in helping smokers quit smoking, but it associated with a higher frequency of self -reported adverse events. (Fund ed by the Health Research Council of New Zealand; Australian New to have beneficial effect on BP in patients with minimally "}